2019
DOI: 10.3389/fimmu.2019.00364
|View full text |Cite
|
Sign up to set email alerts
|

IL33: Roles in Allergic Inflammation and Therapeutic Perspectives

Abstract: Interleukin (IL)-33 belongs to IL-1 cytokine family which is constitutively produced from the structural and lining cells including fibroblasts, endothelial cells, and epithelial cells of skin, gastrointestinal tract, and lungs that are exposed to the environment. Different from most cytokines that are actively secreted from cells, nuclear cytokine IL-33 is passively released during cell necrosis or when tissues are damaged, suggesting that it may function as an alarmin that alerts the immune system after endo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
179
0
3

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 231 publications
(183 citation statements)
references
References 133 publications
1
179
0
3
Order By: Relevance
“…Upon epithelial or endothelial injury, IL-33 is released from damaged cells and induces type-2 innate immunity via activation of group 2 innate lymphoid cells (ILC2s) through its receptor ST2. Activated ILC2s produce Th2 cytokines, IL-5, and IL-13, in a synergistic manner (Chan et al, 2019). IL-5 and IL-13 have been reported to stimulate eosinophil activation and induce eosinophilia and ciliated epithelial cell hypertrophy in the respiratory tissue (Schmid-Grendelmeier et al, 2002;Takatsu and Nakajima, 2008;Tanabe et al, 2008).…”
Section: Discussionmentioning
confidence: 99%
“…Upon epithelial or endothelial injury, IL-33 is released from damaged cells and induces type-2 innate immunity via activation of group 2 innate lymphoid cells (ILC2s) through its receptor ST2. Activated ILC2s produce Th2 cytokines, IL-5, and IL-13, in a synergistic manner (Chan et al, 2019). IL-5 and IL-13 have been reported to stimulate eosinophil activation and induce eosinophilia and ciliated epithelial cell hypertrophy in the respiratory tissue (Schmid-Grendelmeier et al, 2002;Takatsu and Nakajima, 2008;Tanabe et al, 2008).…”
Section: Discussionmentioning
confidence: 99%
“…However, the functional role of IL-33 in LVV patients is unknown. IL-33 is a key regulator of immune responses shown to license innate and adaptive immunity 18,19 .…”
Section: Discussionmentioning
confidence: 99%
“…Activated mast cells, particularly chymase and tryptase positive connective tissue mast cells, release large amounts of CPA3. Interestingly, IL1RL1 is not only present on granulocytes but also expressed constitutively by mast cells and its ligand, IL-33, stimulates mast cell adhesion to laminin, fibronectin, and vitronectin, and mast cell survival, growth, development, and maturation (32). In addition, mast cell-derived tryptase and chymase cleave IL-33 to generate mature active forms (32).…”
Section: Mast Cells Reside In the Airways And Other Organs And Impactmentioning
confidence: 99%
“…Interestingly, IL1RL1 is not only present on granulocytes but also expressed constitutively by mast cells and its ligand, IL-33, stimulates mast cell adhesion to laminin, fibronectin, and vitronectin, and mast cell survival, growth, development, and maturation (32). In addition, mast cell-derived tryptase and chymase cleave IL-33 to generate mature active forms (32). Together, these data suggest that mast cells represent a major target for ICS in ICS-sensitive COPD patients.…”
Section: Mast Cells Reside In the Airways And Other Organs And Impactmentioning
confidence: 99%